Chemoinformaics analysis of Cycloartanone-24 Methylene
| Molecular Weight | 440.756 | nRot | 5 |
| Heavy Atom Molecular Weight | 388.34 | nRig | 23 |
| Exact Molecular Weight | 440.402 | nRing | 5 |
| Solubility: LogS | -6.303 | nHRing | 0 |
| Solubility: LogP | 7.067 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 84 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 5 |
| No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 31 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 87.2452 |
| nHD | 1 | BPOL | 52.1668 |
| QED | 0.425 |
| Synth | 5.447 |
| Natural Product Likeliness | 3.267 |
| NR-PPAR-gamma | 0.04 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.029 |
| Pgp-sub | 0 |
| HIA | 0.014 |
| CACO-2 | -4.998 |
| MDCK | 0.0000103 |
| BBB | 0.567 |
| PPB | 0.996382 |
| VDSS | 1.426 |
| FU | 0.0208615 |
| CYP1A2-inh | 0.018 |
| CYP1A2-sub | 0.479 |
| CYP2c19-inh | 0.064 |
| CYP2c19-sub | 0.964 |
| CYP2c9-inh | 0.091 |
| CYP2c9-sub | 0.403 |
| CYP2d6-inh | 0.121 |
| CYP2d6-sub | 0.857 |
| CYP3a4-inh | 0.338 |
| CYP3a4-sub | 0.623 |
| CL | 12.451 |
| T12 | 0.008 |
| hERG | 0.028 |
| Ames | 0.025 |
| ROA | 0.189 |
| SkinSen | 0.22 |
| Carcinogencity | 0.017 |
| EI | 0.194 |
| Respiratory | 0.739 |
| NR-Aromatase | 0.319 |
| Antiviral | No |
| Prediction | 0.703241 |